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Summary
To better understand the biological implications of the association of ligand with major
histocompatibility complex class I molecules, we have studied the Ld molecule of the mouse .
The culturing of various nonselected cell lines with three different known Ld peptide ligands
resulted in a two- to fourfold specific increase in surface Ld expression as detected by 10 of 11
different monoclonal antibodies (mAbs) recognizing Ld epitopes . These findings suggest that
Ld molecules are not saturated with endogenous peptide ligands and thus have accessible binding
sites . Exploiting this feature of Ld we demonstrate that the physical association of Ld with ligand
is exquisitely specific, indicating that they function in determinant selection . In addition, a
non-peptide-bound antigenic variant of Ld was specifically detected with an exceptional mAb
designated 64-3-7. In comparison with other Ld molecules, 64-3-7+ Ld molecules are not peptide
ligand inducible, are more susceptible to proteolysis, lack 02 microglobulin association, and
display a slower rate of oligosaccharide maturation . In spite of their deficiencies, the non-ligand-
associated 64-3-7 Ld molecules were detected on the surface of all cell types tested; however,
they appear not to be recognized by alloreactive cytotoxic T lyphocytes .
Class I MHC molecules are highly polymorphic 45-kD
membrane glycoproteins that associate noncovalently
with a-2 microglobulin (02m), 1 a non-MHC-encoded,
non-membrane-bound 11-kD polypeptide . Although each
MHC haplotype of the mouse contains approximately 40
class I genes, only a few haveknown functions . For example,
the H-2d haplotype, represented in the BALB/c inbred strain,
expresses three class I molecules designated Kd, Dd, and Ld
that function as classical transplantation antigens. The K, D,
and L molecules on virus-infected or allogeneic cells func-
tion as recognition structures for CTL . Crystallographic
studies revealed that the highly polymorphic ul and cr2 do-
mains ofthe class I molecule combine in an intricate folding
pattern to form a single potential binding site (1-3) . In fact
the putative ligand binding site of the crystallized class I mol-
ecules was found to contain heterogeneous material estimated
to be til-2 kD. In other studies using functional assays, virus-
specificCTL were found to recognize a processed virus-derived
peptide ligand in the context of a self class I molecule (4) .
There are now several examples where the specific virus-derived
peptide has been identified for a given CTL clone (e.g., refer-
'Abbreviations used in this paper. Ag, antigen ; 02m, /3-2 microglobulin ;
BEA, brefeldin A .
ences 5, 6) . Furthermore, these peptide ligands have been found
to be between 5 and 20 amino acids in length . Thus, there
is complete concordance between the crystallographic and func-
tional studies. In spite of this knowledge, direct evidence of
the binding of peptide to class I molecules has been very
difficult to demonstrate using in vitro binding assays analo-
gous to ones previously used to show class II/ligand associa-
tion . Perhaps this difficulty results from the possibility that
the binding site ofisolated class I molecules is saturated with
self-peptide and these ligands have a very slow rate ofdissoci-
ation . Furthermore, functional recognition of a given pep-
tide ligand appears to require binding to only a small per-
centage of the total class I molecules (7) .
The association of class I molecules with peptide ligand
could affect its surface expression and/or CTL recognition
in a qualitative and/or quantitative manner. Of a qualitative
nature, both the ligand and the class I molecule confer
specificity to the interaction with the TCR, i.e., the CTL
recognition of peptide is class I restricted . In spite of this
exquisite specificity of the TCR recognition of the class I
peptide complex in syngeneic responses, the role of peptide
ligand in allogeneic CTL responses or antibody recognition
has yet to be elucidated . Of a quantitative nature, the inter-
action of peptide ligand with class I molecules has recently
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cules in certain cell types (8-10) . Because this peptide-induced
expression was inhibitable by the drug brefeldin A (BFA),
these findings were initially interpreted as an intracellular
phenomenon (8, 10). Furthermore, immunoprecipitation
results clearly showed peptide-specific induction of confor-
mation of theDb c1/x2 domains and 02m assembly (8) . In
separate lines ofinvestigation, thedrugBFAwas used to pro-
vide evidence that peptide association with class I must occur
in the endoplasmic reticulum (ER) in order to potentiate rec-
ognition by virus-specificCTL (11, 12) . Thus, it is tempting
to speculate that selfor foreign peptides associate with newly
synthesized class I molecules and this association is obliga-
tory for egress of class I molecules from the ER and thus
theirplasma membrane expression . If this model were true,
class Imolecules with empty peptidebinding sites might not
exist on the cell surface.
In this communication we report several new observations
relevant to these outstanding questions of the interaction of
class Imoleculeswith theirpeptide ligand. By culturing cells
with labeled peptide ligand, significant levels of exquisitely
specific binding to class I molecules was observed . Further-
more, antigenically distinct class I molecules were identified
at the cell surface that lack peptide ligand binding, (32m as-
sociation, and alloreactive CTL recognition . Our findings
implicate peptide ligand in the antigenic structure, intracel-
lular transport, and function of class I molecules .
Materials and Methods
Mice and Cell Lines.
￿
Splenocytes were obtained from BALB/c
(K'D'L') or BALB/c-H-2dmz (KdDd) mice that were housed in the
animal facility ofDr. DonaldC. Shrefffer, Washington University
School of Medicine, St . Louis, MO. I,Ld Cells and R1.1-L 1 cells
were generated by introducing the Ld gene into murine Ltk-DAP3
(H-2k) fibroblast cells and R1.1 (H-2k) thymoma cells, respectively.
The P815 (H-2d) is a mouse mastocytoma cell line isolated from
aDBA/2mouse. All of the cell lines used were maintained at 37°C,
6.5%COZ in DME (Gibco Laboratories, Grand Island, NY) con-
taining10% FCS(HyClone Laboratories, Logan, UT), 2MM . L-glu-
tamine and 100U/ml penicillin/streptomycin (DME-FCS) . In cer-
tain experiments, ITLd cells were grown in HIA serum-free medium
(Ventrex, Portland, ME) for 7-10 d before the assays.
Peptide Synthesis.
￿
Peptides were synthesized using Merrifield's
solid-phase method (13) on a peptide synthesizer model431A (Ap-
plied Biosystems, Inc . [ABI] Foster City, CA). All peptide syn-
thesis reagents were of high purity (>99%) and supplied byABI .
The resin used for peptide synthesis was phenylacetamidomethyl
(PAM) and was preloaded with 0.5 mM of required amino acid .
All amino acids used were t-Boc protected at the NH2 terminus
and their reactive side chains were protected with the standard
groups recommendedbyABI for t-Boc synthesis, with the excep-
tion ofhistidine. The histidine derivative used wasN-cx=Boc-N-7r-
Benzyloxymethyl-L-histidine supplied by BACHEM Inc. (Torrance,
CA) . The Boc-amino acids were coupled using carbodiimide-
hydroxybenzotriazole coupling cycles as recommended by the
manufacturer . The peptides were simultaneously deprotected and
cleaved from the resin by treatment withanhydrous hydrogen fluo-
ride/anisole/dimethyl sulfide 10 :1:1(vol/vol/vol) for 50 min at0°C .
The cleaved peptide was washed with diethylether to remove or-
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ganic by-products generated duringHF cleavage . Thepeptide was
then extracted from the resin with 30% acetic acid . The acetic
acid wasremoved by rotary evaporation, and the remainingaqueous
peptide solution was diluted fourfold with HZO, shell frozen,
and lyophilized. Peptides were purified (,>90%) by reverse-phase
HPLC and subjected to purity assessment techniques as previously
described (14) .
Flow Cytometry .
￿
Flow cytometry wasperformed as previously
described (15) . Briefly, 2-4 x 105 cells were placed in the wells
of round-bottomed microtiter plates, washed once with HBSS
(lacking phenol red) containing 0.2% BSA/0.1% sodium azide
(FMF medium), andincubatedwith a saturating concentration of
mAb or with FMF medium alone for 30 min at 4°C . The cells
were washed three times with FMF medium and then incubated
with a saturating concentration of fluorescein-conjugated F(ab') Z
fragment, goat anti-mouse IgG, Fc-specific (CooperBiomedical,
Inc., Malvern, PA) for 30 min at 4°C, washed withFMF medium
three times, and finally resuspended in FMF medium containing
10 pg/mlpropidium iodide . Fluorescein-labeled cells were analyzed
using a FRCS IV (Becton-Dickinson&Co., Mountain View, CA)
equipped with an argon laser tuned to 488 nm and operating at
300mW of power. Fluorescence histograms were generated with
logarithmic amplification of fluorescence emitted by single vari-
able cells . Each sample analyzed comprised a minimum of 2 x
10° cells . Mean fluorescence was obtained with logarithmic
amplification of fluorescence intensity expressed in channels,where
4 logs span 256channels (64 channels per log) . TheFRCS machine
has been calibrated such that the relative increase is equal to 10°,
where e = A mean fluorescence (channels)/64 (channels/decade) .
According to this formula, an increase in fluorescence intensity of
40 channels represents a 4.2-fold increase in expression and 30
channels represents a 3-fold increase in expression .
Immunoprecipitation.
￿
Immunoprecipitation of class I molecules
with specificmAbs was performed as previously described (16, 17).
Briefly, cells were labeled with [3sS]methionine and then lysed
with 0.5% NP-40 in Tris-buffer saline, pH 7.0, containing freshly
added PMSF (0.2 mM ; Sigma Chemical Co ., St . Louis, MO) for
30 min on ice. Cell lysates were centrifuged at 100,000g for 1 h
and supernatants were purified by lentil lectin Sepharose-4B (Phar-
macia Fine Chemicals, Piscataway, NJ) affinity chromatography
using 0.5M ac-methylmannoside for elution to obtain the glyco-
protein pool.Theglycoprotein poolswere precleared with an equal
volume of10% (vol/vol/) IgGSorb (The Enzyme Center, Malden,
MA) and PMSF was added to a final concentration of 0.2 mM .
Samples of these glycoprotein antigens were then incubated with
100 p,l of individual mAb ascites for 30 min on ice, followed by
incubation with 1 ml of 10% IgGSorb for 30 min on ice . The
IgGSorb-mAb-antigen (Ag) complexes were washed three times
in cold Tris-buffered saline containing 0.25% NP-40 and 0.2 mM
PMSF. The mAb-Ag complexes were eluted by incubation of the
samples in 0.125M Tris-HCI, pH 6.8, 12.5% glycerol, 2% SDS,
and 1% 2-ME (SDS-PAGE sample buffer) at 90°C for 2 min, fol-
lowed by centrifugation to remove the IgGSorb. SDS-PAGE was
performed on a 10-15% linear polyacrylamide gradient Laemmli
buffer system (18) . Prestained molecularweight standards (Bethesda
Research Laboratories, Gaithersburg, MD)were included on every
gel . The gels were then treated with Enhance (NEN-Dupont,
Boston, MA), dried, and exposed to X-Omat AR film at -70°C
for 2-10 d .
Generation ofL4-specific CTL and Analysis by "Cr Release.
￿
The
in vitro generation of primary Ld-specific CTL and analysis of
function by "Cr release was performed as described (19) . Briefly,
Ld-specific CTL were generated by coculture of 7.5 x 106BALB/c-H-2'-Z responder spleen cells with 3.5 x 106 , 2,000 rad-
irradiated BALB/c stimulator spleen cells in 24-well tissue culture
plates (Linbro ; ICN Biomedicals, Costa Mesa,CA) containing 2 ml
of medium . After 5 d cytotoxic activity was measured in a stan-
dard "Cr-release assay. "Cr-labeled target cells (R1.1-Ld) were
added to the wells of round-bottomed microtiter plates . For anti-
body blocking, 50 Al of target cells were preincubated with 50
pl of antibody for 15 min at 37°C . 100 p.l of effector cells were
added to the wells and the plates were incubated in a humidified
atmosphere at 37°C, 5% CO2. At the end of 4 h, "Cr released
into the supernatant was measured . The percent-specific 5'Cr re-
lease was calculated as 100 x [(experimental "Cr release - spon-
taneous "Cr release)/(maximum "Cr release -, spontaneous 5'Cr
release)] . The SEM percent specific lysis was <5% of the value of
the mean .
Peptide Labeling and Binding .
￿
Peptides were iodinated using the
Iodo-Beads (Pierce Chemical Co ., Rockford, IL) method . Briefly,
Iodo-Beads were washed twice with iodination buffer (100mM
sodium phosphate, pH 7.4) . Two Iodo-Beads were mixed with 5
mCi of Na'"I (New England Nuclear, Boston, MA) in 200 /Al io-
dination buffer at room temperature for 5 min . A solution of 300
,ul of peptide in iodination buffer (at 660 p.M) was added to the
Iodo-Beads reaction mixture . The iodination reaction was allowed
to proceed for 15 min at room temperature and terminated by
removing the reaction mixture from the Iodo-Beads. The radiola-
beled peptide was recovered by transferring the reaction mixture
to a 1 ml packed A6-1x8 ion exchange resin (BioRad Laboratories,
Richmond, CA) column to bind the free "'I . After centrifuga-
tion (2,500 g, 5 min) the radiolabeled peptide-containing fluid forced
through the column was collected and stored at 4°C before use.
Peptides were labeled with specific activities between 0.3 and 1 x
10' 6 cpm/mol . In the peptide binding assay, 3 x 10 1 P815 cells
(2 x 10 6/ml) were cultured with labeled peptides (0.6-2 x 109
cpm) for 6 h or 18 h at 37°C . After culture the cells were washed
twice with PBS and lysed on ice with NP-40 lysis buffer. The ly-
sate was kept at 4°C for 1-2 d, and the glycoprotein pools were
then isolated from the lysate for immunoprecipitation . The radio-
activities of class I precipitates (bound peptide) and supernatants
(non-bound peptide) were determined using a gamma counter .
Results
Peptide Ligand-induced Surface Expression of10 of11 Ld Sero-
logical Epitopes .
￿
In an earlier study, we reported that cul-
Murine cytomegalovirus pp89 .
t Tumor minus P815 variant P91A - .
S Lymphochoriomeningitis virus nucleoprotein .
I Influenza nucleoprotein .
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turing various Ld-positive cell types with peptide ligands led
to a dramatic and specific induction of surface Ld expression
(9) . For these initial experiments two different ligands previ-
ously shown to be recognized by Ld-restricted CTL were
used . The sequence and derivation ofthese two peptides desig-
natedMCMV (pp89 168-176) and turn - (P91A - 12-24), as
well as other peptides used for this study, are listed in Table
1. The Ld-specific surface induction was monitored in these
initial studies using mAbs 30-5-7 and 28-14-8 which recog-
nize epitopes in the class10 and0 domains, respectively .
Because the contribution of the peptide-ligand to antibody
recognition of class I remains unclear, we extended our in-
duction studies to include a panel of 11 differentmAbs (Table
2) to Ld and five different peptide ligands (Table 1) . To test
the various mAbs, L cells transfected with the Ld gene
(L-Ld) were cultured with 10 -4M turn - peptide for 15 h
at 37°C . These conditions were known to induce optimal
surface expression of Ld antigens as measured by indirect im-
munofluorescence. 10 of the 11 mAbs to Ld showed a two-
to fourfold increase in their staining on peptide-treated versus
control cells. By contrast, one of themAbs designated 64-3-7
showed no peptide ligand-increased expression . To extend
this observation, ITLd or P815 cells were cultured with var-
ious concentrations of peptides. As shown in Fig. 1, expres-
sion of Ld epitopes recognized by mAb 30-5-7, 28-14-8, or
66-3-5 increased in a dose-dependent manner in response to
MCMV or turn- peptides . By contrast, treatment with
these peptides resulted in no increase in the expression of the
Ld epitope detected by 64-3-7, or a Kk epitope on theL cells
or a Kd epitope on the P815 cells . In data not shown, the
lack of induction of the epitope recognized by 64-3-7 in con-
trast to other Ld epitopes was also observed using--,the
LCMV NP 118-126 peptide known to be a ligand 'for' l:d .
As specificitycontrols, two other immunogenic peptides,FLU
NP 365-380 and FLU NP 147-158(R - ), known to use
respectively the Db and Kd class I molecules in CTL studies,
were tested, and neither induced expression of Ld antigens.
It is important to note that the Kd-restricted peptide induced
little if any Kd antigen on P815 cells, and the Db-restricted
peptide induced little if any Db expression on EL4 cells in
spite of the fact both are capable of eliciting CTL recogni-
Table 1 . Synthetic Peptides
Peptide
source
Amino acid
residues Known sequence
H-2
restriction Reference
MCMVpp89' 168-176 YPHFMPTNL Ld 5
turn- P91A- t 12-24 ISTQNHRALPLVA Ld 6
LCMV NPS 118-126 RPQASGVYM Ld 27
FLU NPI 365-380 IASNENMETMESSTLE Db 8
FLU NPI 147-158(R - ) TYQRTRALVTG Kd 28tion (data not shown) . Thus, the inducibility of Ld antigens
is specific for certain peptides and Ld appears unique among
other class I molecules . Furthermore, this peptide-specific in-
duction affects all Ld epitopes except the one recognized by
mAb 64-3-7 .
To determine whether the expression of the 64-3-7 epi-
tope was unique for certain cell types, various Ld-positive cell
lines were compared by indirect immunofluorescence . IrLd,
R1.1-Ld, P815, and BALB/c splenocytes expressed the 64-3-7+
Ld epitope (Fig . 2), whereas the nontransfected L cells or
R1.1 cells were negative (data not shown) . To determine if
recognition of Ld by mAbs 30-5-7 and 64-3-7 is 02m depen-
dent, cells were also grown in serum-freemedium . A previous
study (16) showed that in serum-free medium Ld molecules
are detected as free heavy chains . Comparable levels of staining
were observed on IJLd cells grown in serum-free medium
(data not shown) or medium containing FCS (Fig . 2 A) using
either mAb 64-3-7 or 30-5-7 . Thus, both of these Ld epi-
topes are independent of 02m . To determine whether the Ld
epitopes defined by these variousmAbs differ in their suscep-
tibilities to proteolysis, I,Ld cells were treated with 0.05%
trypsin for various amounts of time . For this experiment,
cells were also cultured in serum-free medium to avoid sec-
ondary effects attributable to 02m association . In data not
shown the Ld epitope defined by mAb 64-3-7 showed a
marked time-dependent reduction in expressionon trypsinized
cells . In fact, after only 30 min of treatment, fourfold less
binding of 64-3-7 was observed. By contrast, the Ld epitopes
recognized by mAbs 30-5-7 and 28-14-8 were unaffected by
this treatment . This latter finding is in agreement with ear-
lier reports that showed trypsinization of class I molecules
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Figure 1.
￿
Specific surface induction of certain Ld epitopes after cul-
turing cells with Ld-specific peptide ligands. (A) Dose response of I'Ld
cells to MCMV peptide . (B) Dose response of IrLd to turn - peptide . (C)
Dose response of P815 to MCMV peptide . Ld gene L cell (H-2k) trans-
fectants (IrLd) or P815 cells (H-2d) were incubated with medium alone
or with medium containing the indicated peptide at 0.4, 10, or 250 pM
for 15 h at 37°C, 6.5% C02 . Cells were then analyzed by indirect im-
munofluorescence using themAbs indicated.mAbs 28-14-8, 30-5-7, 66-3-5,
and 64-3-7 were used to detect Ld expression and mAbs 11-4-1 and 215
were used to detect Kk and Kd antigens respectively. A mean fluorescence
(channels) represents the increase in fluorescence intensity of cells treated
with peptides. An increase in fluorescence intensity of40 channels represents
a 4.2-fold increase in expression as described in Materials and Methods .
requires significantly more enzyme and longer incubation times
than that used here (29) . Thus, the Ld epitope recognized
by 64-3-7 is highly and uniquely susceptible to proteolysis
by trypsin .
In BALB/c Lysates, mAbs 30-5-7 and64-3-7 Detect Alterna-
tive Antigenic Forms of the Ld Molecule. The molecular
Table 2 . Monoclonal Antibodies
A.
Class I
mAb Isotype specificity Reference
64-3-7 IgG2b Ld (a2) 20
66-3-5 IgG2a Ld (a2) 21
30-5-7 IgG2a Ld (a2) 22
23-10-1 IgM Ld (a2) 22
1634 IgM Ld (a2) 20
66-2-4 IgG3 Ld (a1/ca2) 21
28-14-8 IgG2a Ld (a3) 22
MA228 IgG3 Ld (a3) 23 a.
66-8-2 IgG2b Ld (a3) 21
66-4-8 IgG2b Ld 21
66-13-5 IgG2b Ld 21
34-5-8 IgG2a Dd (a2) 24
MA215 IgG2b Kd 23
SF1-1.1 .1 IgG2a Kd ATCC HB 159
D04 IgG3 Kd Dd 25
3-83 IgG2a Kk Dk 22
11-4-1 IgG2a Kk 26
C.A . L-Ld B. R11-Ld
Figure 2.
￿
Surface expression of
both 30-5-7 (--) and 64-3-7 ( . . .)
antigenic determinants on (A)
L-Ld, (B) Rl.l-Ld, (G7 P815, and
(D) BALB/c spleen cells. The cells
were analyzed by indirect im-
munofluorescence using a FACS
IV The background histograms
(-) represent fluorescenceemitted
from cells treated only with the
fluorescein-conjugated developing
Relative Fluorescence Intensity
￿
antibody.
a
z
C. P815
￿
D . BALB/c
specificities of 64-3-7+ Ld and 30-5-7+ Ld were compared by
immunoprecipitation analyses . BALB/c (Kd Dd Ld) spleen
cells were biosynthetically labeled with [35S)methionine for
4 h and the glycoprotein pool was purified by lentil lectin
affinity chromatography . Aliquots of theBALB/c antigen prep-
aration were precipitated using the Ld-reactive mAbs 30-5-7,
28-14-8, 64-3-7 and the Kd/Dd-reactive mAb Do4 . As
shown in Fig. 3 A a striking disparity in 92m-association
Figure 3 .
￿
Immunoprecipitates of 35S-labeled spleen cell lysates using var-
ious anti-Ld mAbs. On the autoradiograms of 10-15% gradient SDS-
polyacrylamide gels shown, class I heavy chain molecules resolve into two
distinct bands : Endo Hr, the slower migration band, and Endo H~, the
faster migration band. (A) Immunoprecipitation from 35S-labeled BALB/c
(KdDdLd) spleen cells. BALB/c lysate was immunoprecipitated using
Ld-reactive mAbs 30-5-7 (lane 1), 28-14-8 (lane 2), or 64-3-7 (lane 3) and
Kd/Dd reactive mAb Do4 (lane 4) . (B) Immunoprecipitation from
35S-labeled BALB/c-H-2dm 2 (KdDd) spleen cells. BALB/c-H-2dmz lysate was
immunoprecipitated using Ld-reactive mAbs 64-3-7 (lane 1), 28-14-8 (lane
2), or 30-5-7 (lane 3), and Dd reactivemAb 34-5-8 (lane 4), and Kd reac-
tive mAb 215 (lane 5) .
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was observedamong the class I precipitates. mAb 30-5-7 (lane
1) or 28-14-8 (lane 2) precipitated an Ld heavy chain of N45-
kD associated with 02m, whereas antibody 64-3-7 (lane 3)
precipitated Ld with no detectable 02m . Furthermore, the
28-14-8 and 30-5-7 precipitates contained less 02m than did
the Do4 Kd/Dd precipitate (lane 4) confirming that Ld has
a low avidity for a2m . Another significant finding is that
the 64-3-7 precipitate contained predominantly immature,
endoglycosidase H-sensitive (Endo HS), heavy chains in con-
trast to the 30-5-7 precipitate that contains approximately equal
amounts of immature and mature, endoglycosidase H-resistant
(Endo H7), heavy chains . The basis of this difference be-
tween the 64-3-7 and 30-5-7 precipitates was explored fur-
ther in a pulse-chase experiment described in the next sec-
tion . To confirm that mAbs 64-3-7, 28-14-8, and 30-5-7 are
all specific for Ld in this gel system they were also tested on
a lysate from the Ld-loss mouse strain BALB/c-H-2dm2 (30) .
As shown in Fig. 3 B, all three of the aforementioned mAbs
failed to precipitate class I molecules from the BALB/c-
H-2dm2 1ysate, thus establishing their specificity for Ld . To de-
termine whether mAbs 30-5-7 and 64-3-7 define separate
antigenic forms of Ld, sequential immunoprecipitation ex-
periments were performed using a "S-labeled BALB/c lysate.
The experiment in Fig. 4 A shows the result of preclearing
with mAb 30-5-7 . After complete clearance of all 30-5-7+
Ld molecules (lane 2), both Ld mAbs 28-14-8 (lane 3) and
64-3-7 (lane 4) detected residual, non-#2m-associated heavy
chains . Reciprocally, when a BALB/c lysate was precleared
of 64-3-7+ Ld, residual 02m-associated heavy chains were de-
tected by mAbs 30-5-7 and 28-14-8 (data not shown) . Thus,
mAbs 30-5-7 and 64-3-7 define two separate antigenic forms
of Ld . As expected, when a BALB/c lysate was precleared
Figure 4.
￿
Sequential immunoprecipitation defines two antigenic forms
of Ld, 30-5-7' 64-3-7- 28-14-8' Ld and 30-5-7- 64-4-7+, 28-14-8' Ld.
(A) Sequential immunoprecipitations from 35S-labeled BALB/c spleen cells
pretreated with mAb 30-5-7. The antigen preparation from lysates of
35S-labeled BALB/c spleen cells was pretreated with 30-5-7 (lane 1) . The
supernatant precleared with 30-5-7 was then tested with 30-5-7 (lane 2),
28-14-8 (lane3), 64-3-7 (lane 4), or Do4 (lane 5) . (B) Sequential immuno-
precipitation from 35S-labeled BALB/c spleen cells pretreated with both
mAbs 30-5-7 and 64-3-7 . Lanes 1, 2, and 3 contain test precipitates from
half of the antigen preparation treated, respectively, with 64-3-7, 30-5-7,
or 28-14-8 . The other half of the antigen preparation was pretreated with
a mixture of 30-5-7 and 64-3-7 (lane 4), and then tested with 64-3-7 (lane
5), 30-5-7 (lane 6), and 28-14-8 (lane 7) .with mAb 28-14-8 (a3 domain), neither 30-5-7 nor 64-3-7
detected residual Ld molecules (data not shown) . Thus, both
30-5-7+ Ld and 64-3-7+ Ld are detected with mAb 28-14-8 .
To determine whether 64-3-7+ Ld plus 30-5-7+ Ld account
for all Ld molecules, a mixture of both mAbs was used for
preclearance . For the experiment shown in Fig. 5 B, half of
a BALB/c lysate was used for control precipitates of mAb
64-3-7 (lane 1), 30-5-7 (lane 2), or 28-14-8 (lane 3), whereas
the other half of the lysate was precleared with a mixture
ofmAbs 30-5-7 and 64-3-7 (lane 4) . This latter preparation
was then tested and found to contain no residual 64-3-7+
(lane 5), 30-5-7+ (lane 6), or 28-14-8+ (lane 7) molecules .
Because 28-14-8 recognizes an epitope in the0 domain, it
should detect all Ld molecules . Thus, mAbs 30-5-7 and 64-
3-7 define alternative serological forms of Ld and the com-
bined pool of 30-5-7+ plus 64-3-7+ molecules includes all
Ld molecules .
Disparate Rates of Oligosaccharide Maturation of 64-3-7+ Ld
versus 30-5-7+ Ld Molecules. To compare the relative rates
of intracellular transport of the alternative forms of Ld, a
pulse-chase experiment was performed using metabolically
labeled BALB/c spleen cells . Cells were pulsed with [ 35S]me-
thionine for 15 min followed by a chase period of 15, 60,
Figure 5 .
￿
Chemical comparisons of the alternative antigenic forms of
Ld . (A) Pulse-chase experiment comparing the relative rate of oligosac-
charide maturation of the 30-5-7' Ld versus 64-3-7+ Ld molecules.
BALB/c spleen cells were pulsed with 1355]methionine for 15 min followed
by a chase period of either 15, 60, or 120 min. The antigen preparation
from cells from each respective time point was precipitated with either
mAb 30-5-7 or 64-3-7 . (B) Immunoprecipitation analysis comparing the
two antigenic forms of Ld molecules (30-5-7+ Ld versus 64-3-71 Ld) from
35S-labeled BALB/c spleen cells cultured with or without MCMV pep-
tide. BALB/c spleen cells were incubated in the presence of 10-4 M
MCMV peptide or medium alone for 3 h at 37°C, 6.5% COZ . [35S]me-
thionine was included during the last 2 h ofculture. Lysates from the cells
were then treated with mAb 30-5-7 (lanes 1 and 4), 28-14-8 (lanes 2 and
5), or 64-3-7 (lanes 3 and 6). Lanes 1, 2, and 3 contain precipitates from
cells cultured without peptide. Lanes 4, 5, and 6 contain precipitates from
cells cultured with peptide . From each lysate, the ratio of30-5-7* Ld form
to 64-3-7+ Ld can be observed by comparing precipitate bands in lanes
1 with 3 for control cells and lanes 4 and 6 for cells grown with MCMV
peptide.
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or 120 min . The antigen preparation from cells from each
chase period was precipitated with an excess amount ofmAb
30-5-7 or 64-3-7 . As shown in Fig . 5A both immature (Endo
HS) and mature (Endo H=) forms of 30-5-7+ Ld were de-
tected at each time point . However, comparison of the two
glycan forms indicate a steady but slow rate of maturation
of 30-5-7+ Ld molecules (31) . By comparison, 64-3-7+ Ld
molecules were detected exclusively with immature glycans
at the 15- and 60-min time points, and even after 120 min
only trace amounts of mature 64-3-7+ Ld molecules were
detected . Thus, the alternative serological forms of Ld clearly
have disparate rates of oligosaccharide maturation, implying
a disparate rate of intracellular transport . As also shown in
Fig. 5 A both 30-5-7+ Ld and 64-3-7+ Ld were detected at
each time point and their ratio remained relatively constant
throughout the experiment . Thus, it is difficult to discern
any precursor/product relationships between these antigenic
variants. It is clear, however, from this and other pulse/chase
experiments that mature 64-3-7+ Ld can be detected after
longer chase periods. This finding is consistent with the de-
tection of 64-3-7+ Ld on the cell surface (Fig. 2) . Interest-
ingly, surface 64-3-7+ Ld molecules also show weak if any
02m association, even when cells are grown in medium con-
taining bovine 02m that is known to avidly bind Ld (16) .
As mentioned above, surface 64-3-7+ Ld molecules were
originally detected by flow cytometry due to their lack of
inducibility after culturing cells with Ld-specific peptide
ligands . To extend this observation in a chemical analysis,
we immunoprecipitated the alternative antigenic forms of Ld
from BALB/c spleen cells grown with or without peptide
ligand . In this experiment cells weregrown either in the pres-
ence of 10-4 MMCMV peptide or medium alone for 3 h .
During the last 2 h of culture, ["S]methionine was added
and after lysis, precipitates were obtained using mAbs 30-5-7,
28-14-8, or 64-3-7. As shown in Fig . 5 B, culturing with
peptide ligand significantly altered the ratio of the serolog-
ical forms of Ld detected . Whereas in precipitates from un-
treated cells (lanes 1-3) both antigenic forms of Ld were
clearly detectable, in precipitates from peptide-treated cells
(lane 4-6) little 64-3-7+ Ld were detected. The 28-14-8
precipitate was comparable in both preparations (lanes 2 and
4), thus serving as an internal control representing total Ld .
The effect of peptide treatment on the oligosaccharide matu-
ration of the alternative Ld forms can also be implied from
the data shown in Fig. 5 B . Even though the 30-5-7 precipi-
tate of both treated and untreated cells showed both imma-
ture and mature forms, their ratio appeared unaffected . This
result implies peptide treatment does not affect the rate of
oligosaccharide maturation . By contrast, 64-3-7+ Ld mole-
cules were detected almost exclusively with immature oligosac-
charides from both treated and untreated cells (lanes 3 and
6) . Thus, culturing cells with Ld-specific ligand dramatically
affects the ratio of antigenic forms of Ld detected, but not
their respective rates of oligosaccharide maturation .
The Alternative Serological Forms ofLd Are Distinguished by
Their PhysicalInteraction with Peptide Ligand as well as theirRec-
ognition by Alloreactive CTL . The aforementioned inducibility
of Ld antigens by certain peptides suggests that their bindingThe binding assay was performed by immunoprecipitation from lysates of P815 cells cultured with 1251-MCMV peptide using class I reactive mAbs
as indicated (see Materials and Methods for details) .
" Radioactivity of precipitates (bound peptide) in cpm .
t Radioactivity of supernatants (non-bound peptide) in cpm .
5 Percent precipitable counts = 100 x [pellet cpm/(pellet cpm + sup cpm)] .
sites are accessible to appropriate ligands. To substantiate this
conclusion, P815 cells were cultured for either 6 or 18 h at
37°C with 125l-labeled MCMV peptide. After culture the
cells were lysed and their glycoproteins were purified by lentil
lectin affinity chromotography. Aliquots of these glycopro-
tein pools were then precipitated with variousmAbs as indi-
cated in Table 3 and radioactivity in the supernatant (unbound)
versus the precipitate (bound) was determined . In Exps. 1
and 2, the 30-5-7 precipitate was found to contain 98% and
80% of the precipitable counts, respectively . Background
counts were obtained with mAb 64-3-7 (Ld), 34-5-8 (Da a2
domain), or 3/83 (negative control) . Similarly, in Exp. 3, 98%
of the counts were precipitable by mAb 30-5-7, in contrast
to mAbs 34-5-8 (pd) and SFl-1.1.1 (Kd), each of which
precipitated <2% of the counts. Assuming 1-to-1 stoichiom-
etry and the specific counts shown in Table 3 would suggest
as many as 106 Ld molecules per cell contain the labeled pep-
tide. For example, in Exp. 3, 0.58 x 109 cpm of labeled pep-
tide (300 ug) was added to 3 x 107 P815 cells and 10 7 cell
equivalents were precipitated bymAb 30-5-7 . Thus, the 38,000
cpm precipitated bymAb 30-5-7 would represent 8.0 x 10 12
bound peptides, implying 8.0 x 105 peptides are bound per
P815 cell . To compare the relative amounts of the class I mol-
ecules precipitated by various mAbs used in these experiments,
parallel cultures of P815 cells were labeled with [35S]methi-
onine instead of 1251-peptide. As expected these control pre-
cipitates detected significantly more Kd, Dd, and Ld mole-
cules than alternative forms of Ld molecules (data not
shown) . Using this same protocol we have also observed
specific binding of the LCMV peptide to 30-5-7+ Ld mole-
cules (data not shown) . Furthermore, mAb 28-14-8 (a3 do-
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main) was found to precipitate counts comparable to mAb
30-5-7 (data not shown), thus indicating that the detection
of specific binding to Ld is not dependent upon using a mAb
to the a1/a2 domains. To test the peptide specificity of the
binding to Ld, the Kd-specific FLU NP 147-158(R-) pep-
tide was also tested . Even though this peptide labeled with
comparable specific activity as theMCMV and LCMV pep-
tides, no binding was observed to either Ld or Kd molecules.
These findings thus substantiate the induction studies and
confirm that Ld molecules have accessible binding sites that
specifically bind certain peptide ligands.
The above comparisons indicate that 64-3-7+ Ld mole-
cules differ from 30-5-7+ Ld molecules in their associations
with peptide and 02M . In spite of their deficiencies, how-
ever, 64-3-7+ Ld are expressed on the cell surface at relatively
high levels . It was thus considered relevant to determine
whether 64-3-7+ Ld molecules could be recognized by al-
loreactive CTL. To address this issue, primary cultures ofCTL
were generated in the Ld-specific strain combination
BALB/c-H-Zd'° 2 anti-BALB/c. These effector cells were then
tested for cytotoxicity on "Cr-labeled R1.1-Ld target cells.
To selectively assess recognition of 64-3-7+ Ld versus 30-5-7+
Ld, their respective mAbs were used to block the Ld-specific
CTL response. The results in Fig. 6 A show data obtained
at a fixed concentration ofmAb and various E/T cell ratios.
Alternatively, the results shown in Fig. 6B show a fixedE/T
cell ratio and various concentrations ofmAb. As clearly shown
in both analyses, mAb 30-5-7 was a potent blocker of the
anti-Ld CTL response in contrast to mAb 64-3-7 that did
not block . The lack of alloreactive CTL recognition of
64-3-7+ Ld could be attributable to its lower surface expres-
Table 3 .
Exp .
Binding of '211 Peptide to
Culture
time
Ld Antigen
mAb
Class I
molecule Pellet'
Supt
cpm
Precipitable
counts5
h cpm cpm
1 6 30-3-7 Ld 10,303 441 98
6 64-3-7 Ldalt 49 10,084 <1
6 34-5-8 Dd 151 8,845 <2
6 3-83 Kk Dk 43 10,906 <1
2 18 30-5-7 Ld 7,631 1,936 80
18 64-3-7 Ldalt 54 9,388 <1
18 34-5-8 Dd 121 7,824 <2
18 3-83 Kk Dk 43 8,581 <1
3 6 30-5-7 Ld 38,721 1,526 98
6 34-5-8 Dd 886 38,463 2
6 SP1-1 .1.1 Kd 218 218 <150
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Figure 6 .
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(A) Lysis by L'-specific CTLs at various E/T ratios in the
presence of mAbs (ascites) used at 1:100 dilution . (B) Lysis by Ld-specific
CTLs in the presence ofvarious concentrations ofmAbs at 20 :1 E/T ratio.
The antibodies included in the CTL assay were 30-5-7 ("), 64-3-7 (A),
34-5-8 negative control (0), and no antibody (O) .
sion; however, fluorometric analyses demonstrate that the en-
dogenous Kk and Dk antigens on R1.1-Ld cells are expressed
at levels comparable to 64-3-7+ Ld, yet anti-Kk/Dk CTL
effectively lyse R1.1-Ld target cells (data not shown) . The
lack of64-3-7 blocking might also be explained by its recog-
nition of an epitope sterically distinct from the site recog-
nized by theTCR. Two observations suggest that this is not
the case: (a) all other mAbs to Ld a1/o12 epitopes have been
found to block the anti-Ld CTL responses (data not shown) ;
and (b) mAbs such as 30-5-7 (Fig. 6) show complete blocking
of this CTL response. If 64-3-7 Ldalt and 30-5-7 Ld mole-
cules both function as target antigens, neither mAb should
show complete blocking . These findings thus suggest that
64-3-7+ Ld are qualitatively nonfunctional in allogeneicCTL
responses . Similarity, mAb 30-5-7 and not 64-3-7 has been
found to block peptide-specific syngeneicCTL responses (data
not shown), thus confirming the aforementioned binding
studies that indicated 64-3-7+ Ld molecules lack peptide
ligand .
Discussion
Recent studies suggest that the binding of peptide ligand
to the class I MHC molecule influences its surface expres-
sion . Various cell types have been cultured with known anti-
genic peptide ligands, resulting in the specific induction of
surface expression of their respective class I molecules. The
initial studies of peptide-induced class I expression used the
RMA.S cell line (8) . This variant cell line was obtained by
mutagenesis followed by immunoselection ofa class I-deficient
phenotype. Characterization ofRMA.S cells showed them
to have low levels of Kb and Db molecules on the surface,
in spite of the detection of normal levels of class I- and 02M-
specific message. Furthermore, most of the Db molecules de-
tected in biosynthetic lysates ofRMA.S cells were sensitive
to Endo H, suggesting residency in the ER, and most of
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RMA.S-derived Db molecules could only be detected with
a mAb to the 0 domain suggesting aberrant folding or as-
sembly. Townsend et al . (8) reported that RMA.S cells
specifically increased their surface expression of Kb and'Db
molecules when cultured with high concentrations of pep-
tide ligands for either Kb or Db molecules. They also noted
an increase in the 02m association of RMA.S-derived Db
molecules after peptide induction . These findings were in-
terpreted as evidence that thebinding ofligand to class I mol-
ecules facilitates its folding and assembly with a2m . It could
then be inferred that ligand binding and/or ligand-induced
folding and/or 02m assembly was required for optimal sur-
face expression of class I molecules . Although this conclu-
sion assumes that RMA.S cells have defective transport of
endogenous peptides, the precise lesion(s) in these cells has
yet to be elucidated .
Previous studies of the Ld class I molecule of the mouse
suggest that it bears several unique features, including a weak
avidity for 02m, a slower rate of intracellular transport, and
a lower cell surface expression (31-33) . Furthermore, each
of these deficiencies was found to be approximately three-
fold, suggesting they are interdependent . To determine
whether the weak avidity for 02m caused the slower trans-
port and lower expression of Ld, we overproduced 02m by
transfection. Unexpectedly, the increased expression of 102m
was found not to result in a higher surface expression of Ld
(unpublished data) . Since 02m appeared not to be the lim-
iting factor controlling Ld expression, experiments were per-
formed to test whether peptide ligand influenced Ld expres-
sion . Using the peptide feeding protocol reported withRMA.S
cells, we have now tested three different peptides known to
be recognized by Ld-restricted CTL . All three peptides were
found to significantly and specifically induce surface expres-
sion of Ld on L cell Ld gene transfectants as well as P815
mastocytoma cells. These findings suggest that aberrant ex-
pression of Ld results from an impairment in binding pep-
tide ligands. Either there is an insufficient pool ofself-peptides
capable of binding Ld or the Ld molecule is more selective
in its ligand binding than other class I molecules . Alterna-
tively, the structure of Ld may render it more dependent
upon peptide to retain its conformation and prevent its denatu-
ration . In any case these findings indicate that there is not
an exhaustive supply of self peptides necessary for maximal
expression of Ld, thus leaving their ligand binding site avail-
able for foreign peptides. Perhaps this property of Ld is a
contributing factor towhy several virus-specificCTL responses
are Ld restricted (34-36) . It will be interesting to determine
whether other class I molecules with suboptimal expression
such as Dk (37) and HLA.C (38-40) antigens share this
property with Ld .
Another peculiar feature of Ld is its detection in all cell
types intwo distinct antigenic forms or conformational vari-
ants. Originally these alternative forms of Ld were distin-
guished by their reactivity with mAb 30-5-7 . Thus, 30-5-7-
Ld molecules could only be detected by preclearance of all
30-5-7+ Ld molecules followed by precipitation with mAb
28-14-8 that detects an0 domain epitope (16) . In this paper
we show that 30-5-7 - Ld molecules can be directly detectedusing antibody 64-3-7, and 64-3-7+ Ld molecules have been
designated Ldalt (for alternative form) . Comparisons of Ld
and Malt have shown they have disparate avidity for 02M-
In serum-free medium neither surface Ld nor Malt is as-
sociated with a2m, demonstrating that their antigenic dif-
ference reflects a conformational difference in the Ld heavy
chain . In pulse-chase experiments the rate of oligosaccharide
maturation of Ld is clearly faster than Ldalt, indicating a
preferential transport of Ld . After culture with specific pep-
tide ligands, the surface expression only of Ld and not Ldalt
molecules was increased . In addition, culturing LLd trans-
fected fibroblasts (9) or BALB/c spleen cells (Fig . 6 B) with
specific ligand resulted in a significant decrease in the amount
of Ldalt versus Ld detected in cell lysates . Finally, in binding
assays, only 30-5-7 + Ld molecules bound the MCMV pep-
tide, in contrast to 64-3-7+ Ldalt molecules that showed no
binding. Thus, all three of the above comparisons indicated
that the alternative antigenic forms of Ld are distinguished
by their interaction with peptide ligand . Our data also sug-
gest that 64-3-7+ Ldalt molecules have empty binding sites .
If Ldalt molecules merely bound a separate pool of ligands,
then they would not have shown the deficient 02m assembly
or the slower intracellular transport . Sequential immunopre-
cipitation experiments indicate that the combined 30-5-7+
Ld plus 64-3-7+ Ld precipitates account for all Ld molecules .
Furthermore, culturing with peptide ligands was found to
induce the expression of all Ld epitopes tested except for the
64-3-7 epitope. These findings suggest that the mAbs de-
tecting inducible Ld epitopes cannot discriminate which pep-
tide is bound and that they detect a common antigenic sub-
population of Ld molecules . Given that Ld and Ldalt are
distinguished by their interaction with peptide, it could be
proposed that ligand sterically blocks only the 64-3-7 epi-
tope. Thus, 64-3-7+ molecules would simply be Ld mole-
cules with empty binding sites, whereas 64-3-7- Ld mole-
cules would contain a bound ligand . However, this model
would not explain why 64-3-7+ molecules are negative for
all other al/a2 Ld epitopes tested . It is important to note
that the lack of 30-5-7 recognition of the Ldalt molecule
cannot be attributed to its lack of fl2m association, since
30-5-7 is capable of recognizing free Ld heavy chains . An al-
ternative model supported by both the serological and pro-
teolysis data is that the 64-3-7 epitope is exposed, and other
Ld epitopes are lost by partially denatured Ld molecules .
Thus, Ldalt molecules could be ER-retained class I molecules
awaiting components required for folding or post-ER class
I molecules that underwent denaturation . Regardless ofwhich
model is correct, the results reported here clearly demonstrate
that peptide ligand influences the antigenic structure of the
class I molecule. Furthermore, the availability of the unique
mAb 64-3-7 should be invaluable for detecting and isolating
a homogeneous population of non-ligand-associated class I
molecules for structural (crystallographic) and cell biological
studies .
An unexpectedly high level of Ldalt molecules was de-
tected on the surface of all cell types tested including spleen,
mastocytoma, and Ld gene-transfected cells . This finding
implies that non-ligand-associated class I molecules are ex-
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pressed on the cell surface at relatively high levels. In addi-
tion to their failure to be ligand-associated, surface Ldalt
molecules bind little if any mouse or bovine ,32m and are
not recognized by alloreactive CTL . Thus, Ldalt molecules
are clearly nonfunctional, reflecting either a lack of native
conformation or a requirement ofCTL for recognition of
02m or peptide ligand. We can envisage two nonmutually
exclusive models that would explain the occurrence of Ldalt
molecules on the cell surface . If culturing cells with peptide
ligand only affects class I molecules in the ER, then it could
be proposed that Ldalt molecules accumulate in the ER until
appropriate peptide ligand becomes available. Once Ldalt
molecules interact with peptide, correct folding occurs,
resulting in the acquisition of several Ld epitopes and the loss
of the 64-3-7 epitope . It could then be proposed that the ac-
cumulation of Ldalt molecules permits them to escape ER
retention, thus allowing them to be transported to the cell
surface. Consistent with this model, no peptide-induced ex-
pression of surface Ld molecules was observed at 15°C, sug-
gesting that transport of newly synthesized Ld molecules is
required for induction (data not shown) . Alternatively, if cul-
turing cells with peptides affects post-ER class I molecules
then it could be proposed that specific ligand can stabilize
the Ld structure and prevent denaturation . In this model,
peptide ligand, 02m, and/or other intracellular factors could
control proper folding, and proper folding could be a prereq-
uisite for egress from the ER. Ld molecules without a bound
ligand might be more susceptible to denaturation . Supplying
an exogenous source of a high concentration of appropriate
ligand would then decrease the turnover of Ld molecules and
thus increase their surface expression . Consistent with this
model BFA preferentially affects surface expression of Ld rel-
ative to Kd or Dd molecules, suggesting Ld molecules have
a higher turnover (manuscript in preparation) . Regardless of
the validity of each of these models, our studies clearly in-
dicate that the interaction of peptide with Ld influences
folding, serology, assembly, and function ofclass I molecules .
Whether each of these effects are the direct result of peptide
ligand engagement remains to be established .
An adjunct to the study reported here is the demonstra-
tion that the binding of peptide ligand to Ld is exquisitely
specific. Exploiting the fact that Ld molecules have accessible
binding sites, P815 cells were cultured with radiolabeled pep-
tides using conditions analogous to our aforementioned sur-
face induction studies. Using this assay we found that Ld
molecules account for asmuch as98% of glycoprotein-bound
peptide from the cell lysate, whereas Dd and Kd molecules
showed no detectable binding. Furthermore, two different
known Ld ligands showed specific binding, whereas a
known Kd ligand showed no detectable binding to either Ld
or Kd molecules . Thus, these results substantiate the pep-
tide-induced expression studies and demonstrate that the rela-
tionship of Ld with peptide ligand is unique and highly
specific . Three relevant reports havejust been published that
employ RMA/RMA.S cells to study class I ligand interac-
tion (41-43) . In one of these studies, RMA.S cells grown
at 19-33°C were found to express high levels of surface class
I-02m complexes (41) . These complexes did not present en-dogenous antigen and were thus presumed to have empty
ligand-binding sites . In support of this conclusion, direct
binding of peptide was observed to RMA.S (and to a lesser
extent RMA) cells cultured at 26°C (42) . Because the empty
class I molecules on the surface ofRMA.S cells were found
to be thermolabile at 37°C, these authors concluded that pep-
tide ligand is important for maintaining the class I structure
(42) . However, our detection of high levels of non-ligand-
associated Ldalt molecules on the surface would appear
to contradict this conclusion . In another study, lysates of
RMA.S/RMA cells (grown at 37°C) were combined with
peptide ligand at 4°C overnight and ligand binding, assembly,
and the gain of antigenic epitopes, were observed (43) . In
agreement with the results reported here, this latter report
presented evidence that the peptide ligand association with
class I is exquisitely specific (43) . It will be very important
in future investigations to determine the relationship between
the alternative forms of Ld reported here and the tempera-
ture-dependent antigenic forms of class I molecules detected
in RMA.S cells.
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